David Brown

Prof. Dr. David Brown

Department of Biology and Biochemistry, University of Bath, Bath BA2 7AY, UK
orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 1997 in Nature
Verified
Journal Article
Closed access
PDF file
DBDavid Brown
David Brown
KQKefeng Qin
Kefeng Qin
JHJochen W. Herms
Jochen W. Herms
AMAxel Madlung
Axel Madlung
JMJean Manson
Jean Manson
HKHans Kretzschmar
Hans Kretzschmar

1 March 1996 in Nature
Verified
Journal Article
Closed access
DBDavid Brown
David Brown
BSBernhard Schmidt
Bernhard Schmidt
HKHans A. Kretzschmar
Hans A. Kretzschmar

1 July 1997 in Experimental Neurology
Verified
Journal Article
Closed access
DBDavid Brown
David Brown
WSWalter J. Schulz-Schaeffer
Walter J. Schulz-Schaeffer
BSBernhard Schmidt
Bernhard Schmidt
HKHans A. Kretzschmar
Hans A. Kretzschmar

11 May 2004 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
DBDavid Brown
David Brown
Henryk KozłowskiHenryk Kozłowski
Henryk Kozłowski
A change of the prion protein conformation results in a class of neurodegenerative diseases called the transmissible spongiform encephalopathies (like mad cow and Creutzfeld–Jakob diseases). The function of the normal prion protein is unknown, although much of recent research demonstrates the it may be a copper binding protein selective for Cu(II). Amyloid precursor protein (APP) releases the 39–42 amino acid peptide, a major constituent of the deposit in plaques of Alzheimer disease brain. Also APP is a metal binding protein, including copper ions. The link between copper and both proteins may provide insight into the role of metals in neurodegenerative pathologies.

3 September 2019 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
DADafina M. Angelova
Dafina M. Angelova
DBDavid Brown
David Brown
The single largest risk factor for etiology of neurodegenerative diseases like Alzheimer’s disease is increased age. Therefore, understanding the changes that occur as a result of aging is central to any possible prevention or cure for such conditions. Microglia, the resident brain glial population most associated with both protection of neurons in health and their destruction is disease, could be a significant player in age related changes. Microglia can adopt an aberrant phenotype sometimes referred to either as dystrophic or senescent. While aged microglia have been frequently identified in neurodegenerative diseases such as Alzheimer’s disease, there is no conclusive evidence that proves a causal role. This has been hampered by a lack of models of aged microglia. We have recently generated a model of senescent microglia based on the observation that all dystrophic microglia show iron overload. Iron‐overloading cultured microglia causes them to take on a senescent phenotype and can cause changes in models of neurodegeneration similar to those observed in patients. This review considers how this model could be used to determine the role of senescent microglia in neurodegenerative diseases. image

15 March 2000 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
DBDavid Brown
David Brown
FHFarida Hafiz
Farida Hafiz
LGLeslie L. Glasssmith
Leslie L. Glasssmith
Boon-Seng WongBoon-Seng Wong
Boon-Seng Wong
IJIan M. Jones
Ian M. Jones
SHStephen J. Haswell
Stephen J. Haswell
The prion protein (PrP) binds copper and has antioxidant activity enhancing the survival of neurones in culture. The ability of the PrP to bind other cations was tested and it was found that only manganese could substitute for copper. Although initially manganese‐loaded PrP exhibited similar structure and activity to copper‐loaded PrP, after aging, manganese‐loaded PrP became proteinase resistant and lost function. It was also found that manganese could be incorporated into PrP expressed by astrocytes and that this PrP was partially proteinase resistant. These results show that it is possible to generate proteinase‐resistant PrP from cells and suggest a possible mechanism for the formation of the scrapie isoform of the PrP as generated in sporadic prion disease.